ESMO 2019: First in human study of HIF-2α inhibitor in patients with advanced kidney cancer
Results from the first in human study of the HIF-2α [...]
ESMO 2019: Results from the TRAXAR study to assess TRC105 plus axitinib for metastatic kidney cancer
Results from the TRAXAR clinical trial to assess TRC105 plus [...]
ESMO 2019: Results from JAVELIN-Renal 101 trial for sarcomatoid kidney cancer
Results from the JAVELIN-Renal 101 clinical trial to assess avelumab [...]
ESMO 2019: Results from TITAN-RCC tailored immunotherapy clinical trial
Results from the TITAN-RCC clinical trial to assess tailored immunotherapy [...]
ESMO 2019: Results from SORCE clinical trial with adjuvant sorafenib
Results from the SORCE clinical trial to assess sorfenib as [...]
ESMO 2019: Results from ENTRATA clinical trial with telaglenastat plus everolimus for pre-treated kidney cancer
Results from the ENTRATA clinical trial to assess telaglenastat in [...]
Medicine supply if there is a no-deal Brexit
The government and NHS are working hard to ensure patients [...]
Government pledges to overhaul cancer screening
The government has pledged an overhaul of cancer screening to [...]
Sorafenib versus observation following surgery for metastatic kidney cancer
A potential treatment for a selected group of patients with [...]
‘Revolutionary’ tumour agnostic drug approved for use in Europe
Described by NHS England as "revolutionary" and an "exciting new [...]
